Patient Portal
(561) 886-0976
Toggle navigation
Home
What's
New
About Us
Dr. Mark Rosenberg
The Team
ICT Overview
Testimonials
Research Institute
Program
Diagnostics
Treatment Days
Funding Options
Therapy
Optimizing my Chances for Successful Cancer Treatment
Low-Dose Metronomic Chemotherapy
pH Manipulation Therapy
IV Therapies
Diet and Nutrition
Supplements / Nutraceuticals
Off Label Use of Pharmaceuticals
Offshore Clinical Trials
Intra-tumoral Treatment
Intravenous Albumin infusions
Understanding the Differences
DCA (Dichloroacetate)
Immunotherapy Using Checkpoint Inhibitors
High Risk for
Recurrence of
Cancer
Science
Why Consider Alternatives to Conventional Chemotherapy?
Cancer Stem Cells
Research
News
Videos
Research & Clinical Studies
Library
Contact Us
News
Videos
Research & Clinical Studies
Research &
Clinical Studies
Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy
Intermittent High Dose Proton Pump Inhibitor Improves Progression Free Survival as Compared to Standard Chemotherapy in the First Line Treatment of Patients with Metastatic Breast Cancer